bromocriptine has been researched along with eticlopride in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burris, TP; Freeman, ME; Stringer, LC | 1 |
| Arnold, WS; Touchet, N; Trugman, JM; Wooten, GF | 1 |
| Azaryan, AV; Clock, BJ; Cox, BM | 1 |
| Arita, J; Hashi, A; Hoshi, K; Mazawa, S; Suzuki, S | 1 |
| Aniasi, A; Close, FT; Fitch, C; Freeman, ME; Rosso di San Secondo, VE; Sirchia, G | 1 |
| Coronas, V; Jourdan, F; Krantic, S; Moyse, E | 1 |
| Doherty, JM; Edwards, S; Galindo, DG; Hughes, PD; Scott, AM; Simmons, DL; Wilcox, RE | 1 |
| Floresco, SB; St Onge, JR | 1 |
| Cenci, MA; Lindgren, HS; Ohlin, KE | 1 |
| Al-Azzawi, H; Clayton, RN; Farrell, WE; Hofland, LJ; Richardson, A; Yacqub-Usman, K | 1 |
10 other study(ies) available for bromocriptine and eticlopride
| Article | Year |
|---|---|
Pharmacologic evidence that a D2 receptor subtype mediates dopaminergic stimulation of prolactin secretion from the anterior pituitary gland.
Topics: Animals; Bromocriptine; Cells, Cultured; Dopamine; Dopamine Agents; Dopamine Antagonists; Female; Phenethylamines; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Salicylamides | 1991 |
D1 dopamine agonist effects assessed in vivo with [14C]-2-deoxyglucose autoradiography.
Topics: Animals; Autoradiography; Behavior, Animal; Benzazepines; Brain; Bromocriptine; Deoxyglucose; Glucose; Male; Oxazines; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Salicylamides; Substantia Nigra | 1989 |
Mu opioid receptor mRNA in nucleus accumbens is elevated following dopamine receptor activation.
Topics: Animals; Benzazepines; Bromocriptine; Cocaine; Dopamine Antagonists; Male; Naphthalenes; Nucleus Accumbens; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Opioid, mu; RNA, Messenger; Salicylamides; Transcription, Genetic; Up-Regulation | 1996 |
D2 dopamine-receptor-mediated inhibition of proliferation of rat lactotropes in culture is accompanied by changes in cell shape.
Topics: Actins; Animals; Bromocriptine; Cell Division; Cell Size; Cell Survival; Cells, Cultured; Culture Media, Serum-Free; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Fluorescent Antibody Technique; Microscopy, Phase-Contrast; Pituitary Gland, Anterior; Prolactin; Rats; Receptors, Dopamine D2; Salicylamides; Time Factors | 1998 |
Bromocriptine markedly inhibits progression of murine retrovirus-induced immunodeficiency.
Topics: Animals; Bromocriptine; Cell Line; Dopamine Antagonists; Female; Leukemia Virus, Murine; Lymph Nodes; Lymphatic Diseases; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Salicylamides; Spleen | 1998 |
Dopamine receptor coupling to adenylyl cyclase in rat olfactory pathway: a combined pharmacological-radioautographic approach.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Animals; Autoradiography; Benzazepines; Bromocriptine; Carbachol; Colforsin; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Antagonists; Enzyme Activation; GTP-Binding Proteins; Guanosine Triphosphate; Male; Muscarinic Agonists; Nitriles; Odorants; Olfactory Bulb; Olfactory Mucosa; Olfactory Pathways; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Signal Transduction | 1999 |
Antagonistic effects of dopaminergic signaling and ethanol on protein kinase A-mediated phosphorylation of DARPP-32 and the NR1 subunit of the NMDA receptor.
Topics: Animals; Benzazepines; Bromocriptine; Corpus Striatum; Cyclic AMP-Dependent Protein Kinases; Dopamine; Dopamine Agonists; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Antagonists; Ethanol; Male; Mice; Nerve Tissue Proteins; Phosphoproteins; Phosphorylation; Receptors, N-Methyl-D-Aspartate; Salicylamides; Signal Transduction | 2002 |
Dopaminergic modulation of risk-based decision making.
Topics: Animals; Behavior, Animal; Benzamides; Benzazepines; Benzopyrans; Bromocriptine; Conditioning, Operant; Decision Making; Dextroamphetamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Naphthalenes; Oxazines; Piperazines; Pyridines; Pyrroles; Pyrrolidines; Rats; Rats, Long-Evans; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4; Reinforcement Schedule; Risk; Salicylamides | 2009 |
Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aminoacetonitrile; Animals; Antiparkinson Agents; Basal Ganglia; Benzazepines; Bromocriptine; Disease Models, Animal; Dopamine Agents; Dopamine D2 Receptor Antagonists; Extracellular Signal-Regulated MAP Kinases; Female; Levodopa; Neovascularization, Pathologic; Oxidopamine; Parkinsonian Disorders; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides | 2009 |
Reversal of endogenous dopamine receptor silencing in pituitary cells augments receptor-mediated apoptosis.
Topics: Animals; Apoptosis; Bromocriptine; Cell Line; Chromatin Immunoprecipitation; DNA Methylation; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Histones; Pituitary Gland; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Salicylamides | 2011 |